Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | NVP-TAE684 | 0.1 | uM | 4 | 625.00 | 288.04 | 702.00 | 818.25 | 0.8579 | 0.8065 |
| BT-20 | NVP-TAE684 | 0.01 | uM | 4 | 625.00 | 288.04 | 1179.00 | 818.25 | 1.4409 | 1.5488 |
| BT-20 | 0 | uM | 4 | 625.00 | 288.04 | 1085.00 | 818.25 | 1.3260 | 1.4120 | |
| BT-20 | Nilotinib | 0.01 | uM | 4 | 625.00 | 288.04 | 1060.00 | 818.25 | 1.2954 | 1.3750 |
| BT-20 | 0 | uM | 4 | 625.00 | 288.04 | 851.00 | 818.25 | 1.0400 | 1.0528 | |
| BT-20 | NVP-TAE684 | 0.31623 | uM | 4 | 625.00 | 288.04 | 757.00 | 818.25 | 0.9252 | 0.8993 |
| BT-20 | Etoposide | 0.01 | uM | 4 | 625.00 | 288.04 | 864.00 | 818.25 | 1.0559 | 1.0736 |
| BT-20 | Etoposide | 1 | uM | 4 | 625.00 | 288.04 | 458.00 | 818.25 | 0.5597 | 0.3606 |
| BT-20 | PLX-4720 | 10 | uM | 4 | 625.00 | 288.04 | 643.00 | 818.25 | 0.7858 | 0.7043 |
| BT-20 | Etoposide | 10 | uM | 4 | 625.00 | 288.04 | 282.00 | 818.25 | 0.3446 | -0.0140 |
| BT-20 | Nilotinib | 0.0033113 | uM | 4 | 625.00 | 288.04 | 945.00 | 818.25 | 1.1549 | 1.2007 |
| BT-20 | PLX-4720 | 0.01 | uM | 4 | 625.00 | 288.04 | 610.00 | 818.25 | 0.7455 | 0.6457 |
| BT-20 | 0 | uM | 4 | 625.00 | 288.04 | 722.00 | 818.25 | 0.8824 | 0.8406 | |
| BT-20 | 0 | uM | 4 | 625.00 | 288.04 | 581.00 | 818.25 | 0.7101 | 0.5933 | |
| BT-20 | 0 | uM | 4 | 1250.00 | 665.42 | 1431.00 | 2022.25 | 0.7076 | 0.6120 | |
| BT-20 | 0 | uM | 4 | 1250.00 | 665.42 | 1842.00 | 2022.25 | 0.9109 | 0.8869 | |
| BT-20 | Etoposide | 19.9526 | uM | 4 | 1250.00 | 665.42 | 434.00 | 2022.25 | 0.2146 | -0.2339 |
| BT-20 | 0 | uM | 4 | 1250.00 | 665.42 | 1620.00 | 2022.25 | 0.8011 | 0.7417 | |
| BT-20 | Nilotinib | 0.1 | uM | 4 | 1250.00 | 665.42 | 2270.00 | 2022.25 | 1.1225 | 1.1495 |
| BT-20 | PLX-4720 | 0.31623 | uM | 4 | 1250.00 | 665.42 | 2167.00 | 2022.25 | 1.0716 | 1.0881 |
| BT-20 | Nilotinib | 10 | uM | 4 | 1250.00 | 665.42 | 1130.00 | 2022.25 | 0.5588 | 0.3913 |
| BT-20 | NVP-TAE684 | 3.1623 | uM | 4 | 1250.00 | 665.42 | 697.00 | 2022.25 | 0.3447 | 0.0293 |
| BT-20 | NVP-TAE684 | 10 | uM | 4 | 1250.00 | 665.42 | 503.00 | 2022.25 | 0.2487 | -0.1601 |
| BT-20 | PLX-4720 | 3.1623 | uM | 4 | 1250.00 | 665.42 | 2325.00 | 2022.25 | 1.1497 | 1.1818 |
| BT-20 | PLX-4720 | 1 | uM | 4 | 1250.00 | 665.42 | 2101.00 | 2022.25 | 1.0389 | 1.0482 |